Although the heterogeneity of this study is relatively high, considering that we are attempting to explore the efficacy of PD-1/PD-L1 inhibitors and their impact on NPC from a holistic perspective, this is acceptable. This evidence concerns the gene CD274 and nasopharyngeal carcinoma.